Switch theme
Sign up to access all valuation multiples
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
2006
5
LTM Revenue $3.1M
Last FY EBITDA $46K
$8.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Redsense Medical has a last 12-month revenue (LTM) of $3.1M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Redsense Medical achieved revenue of $2.9M and an EBITDA of $46K.
Redsense Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Redsense Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1M | XXX | $2.9M | XXX | XXX | XXX |
| Gross Profit | $3.1M | XXX | $1.9M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 64% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | $46K | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 2% | XXX | XXX | XXX |
| EBIT | $43K | XXX | $22K | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Profit | -$0.3M | XXX | $35K | XXX | XXX | XXX |
| Net Margin | -10% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Redsense Medical's stock price is SEK 6 (or $1).
Redsense Medical has current market cap of SEK 100M (or $10.3M), and EV of SEK 84.3M (or $8.7M).
See Redsense Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8.7M | $10.3M | XXX | XXX | XXX | XXX | $-0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Redsense Medical has market cap of $10.3M and EV of $8.7M.
Redsense Medical's trades at 3.0x EV/Revenue multiple, and 189.9x EV/EBITDA.
Equity research analysts estimate Redsense Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Redsense Medical has a P/E ratio of -34.2x.
See valuation multiples for Redsense Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $10.3M | XXX | $10.3M | XXX | XXX | XXX |
| EV (current) | $8.7M | XXX | $8.7M | XXX | XXX | XXX |
| EV/Revenue | 2.8x | XXX | 3.0x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 189.9x | XXX | XXX | XXX |
| EV/EBIT | 203.8x | XXX | 403.4x | XXX | XXX | XXX |
| EV/Gross Profit | 2.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | -34.2x | XXX | 293.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -9.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialRedsense Medical's last 12 month revenue growth is 19%
Redsense Medical's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.4M for the same period.
Redsense Medical's rule of 40 is 2% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Redsense Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Redsense Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 19% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 2% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 2% | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 63% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Redsense Medical acquired XXX companies to date.
Last acquisition by Redsense Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Redsense Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Redsense Medical founded? | Redsense Medical was founded in 2006. |
| Where is Redsense Medical headquartered? | Redsense Medical is headquartered in Sweden. |
| How many employees does Redsense Medical have? | As of today, Redsense Medical has 5 employees. |
| Is Redsense Medical publicy listed? | Yes, Redsense Medical is a public company listed on SAT. |
| What is the stock symbol of Redsense Medical? | Redsense Medical trades under REDS ticker. |
| When did Redsense Medical go public? | Redsense Medical went public in 2019. |
| Who are competitors of Redsense Medical? | Similar companies to Redsense Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Redsense Medical? | Redsense Medical's current market cap is $10.3M |
| What is the current revenue of Redsense Medical? | Redsense Medical's last 12 months revenue is $3.1M. |
| What is the current revenue growth of Redsense Medical? | Redsense Medical revenue growth (NTM/LTM) is 19%. |
| What is the current EV/Revenue multiple of Redsense Medical? | Current revenue multiple of Redsense Medical is 2.8x. |
| Is Redsense Medical profitable? | Yes, Redsense Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
